This integrated perspective reconciles similarities and differences among AD, PD, and HD and underscores the importance of preserving BDNF–ERK signaling integrity as a unifying therapeutic strategy across neurodegenerative diseases. The gene discussed is MAPK1; the disease is Huntington disease.